Selpercatinib is the first drug from Loxo's pipeline that Lilly has brought to market.
Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG.

Flair also analysed dozens of open letters published by alumnae of private schools who complained last year about racist abuse they had endured in schools and a lack of black role models among teachers.

The teams' former medic, who is currently facing a fit-to-practise tribunal, paints a stark picture of the gold-medal factory across 66 pages of eye-opening claims within his written defence, which was disclosed over the weekend.

Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky.

Education Secretary Miguel Cardona said Monday that Puerto Rico will receive nearly $4 billion in federal education pandemic relief funds to help boost the U.S.
territory?s fight against COVID-19. SAN JUAN, Puerto Rico (AP) - U.S.

Selpercatinib is the first drug from Loxo's pipeline that Lilly has brought to market.
Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG.